Announced Thu, 2 Jul · 20:30 IST
Vaishali Pharma board approves capital hike, defers share allotment
Corporate Actions View source PDF
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.7%1-day move
₹7.23
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+3.7+2.9+0.1-0.4+4.6+10.1+7.1———
Up moveDown movePending
AI summary
Board approved raising Authorised Share Capital from INR 27 crore to INR 29 crore, divided into 14.5 crore equity shares of INR 2 each, subject to member approval via postal ballot. The proposal to issue and allot 61,23,000 equity shares of INR 2 each was deferred.
Likely market impact
Authorised capital hike creates room for future fundraising, but the actual share issue was deferred, leaving near-term dilution unclear.